MedTrace Logo

Outcome of TAMIS Mucosal Resection in Patients With ODS

NCT06522399 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2024-07-26

No results posted yet for this study

Summary

Patients, aged 18 - 90 years, undergoing TAMIS mucosectomy at the Department of General Surgery at the Medical University of Vienna are enrolled into our study.

Primary endpoint is the outcome (improvement of ODS symptoms), defined by ODS score.

Conditions

  • Constipation, Impaction, and Bowel Obstruction
  • TAMIS Mucosectomy
  • Obstructed Defecation Syndrome

Interventions

PROCEDURE

TAMIS mucosectomy

internal Delorme's procedure using TAMIS

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Stefan Riss, MD · Medical University of Vienna, Head of Pelvic Floor surgery

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2023-10-01
Completion
2023-10-01

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06522399 on ClinicalTrials.gov